A critical role for natural killer T cells in immunosurveillance of methylcholanthrene-induced sarcomas

Journal of Experimental Medicine

Volumn 196, Issue 1, 2002, Pages 119-127

  Crowe, Nadine Y ^a   Smyth, Mark J ^b   Godfrey, Dale I ^a  

^a MONASH UNIVERSITY MEDICAL SCHOOL   (Australia)

^b PETER MACCALLUM CANCER CENTRE   (Australia)

Author keywords

Methylcholanthrene; NK cells; NKT cells; Rodent; Tumor immunity

Indexed keywords

3 METHYLCHOLANTHRENE; CD1 ANTIGEN; CD1D ANTIGEN; CD8 ANTIGEN; GALACTOSYLCERAMIDE; GAMMA INTERFERON; INTERLEUKIN 12; PERFORIN; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN RECOGNITION; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER IMMUNOTHERAPY; CONTROLLED STUDY; EFFECTOR CELL; GENE TARGETING; IMMUNOSURVEILLANCE; INTERFERON PRODUCTION; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; SARCOMA; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; TUMOR IMMUNITY; TUMOR MODEL; TUMOR REJECTION;

ANIMALS; ANTIGENS, CD1; CARCINOGENS; CELL DIVISION; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; FIBROSARCOMA; GALACTOSYLCERAMIDES; GENE TARGETING; IMMUNOLOGIC SURVEILLANCE; IMMUNOTHERAPY, ADOPTIVE; INTERFERON TYPE II; KILLER CELLS, NATURAL; LIVER; LYMPHOCYTES; METHYLCHOLANTHRENE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEOPLASM TRANSPLANTATION; RECEPTORS, ANTIGEN, T-CELL; SARCOMA, EXPERIMENTAL; T-LYMPHOCYTES; TUMOR CELLS, CULTURED;

EID: 0036645278     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.20020092     Document Type: Article

References (45)

1. Mouse CD1-specific NK1 T cells: Development, specificity, and function
2. NKT cells: Facts, functions and fallacies
3. The CD1 family of lipid antigen-presenting molecules
4. Requirement for Vα14 NKT cells in IL-12-mediated rejection of tumors
5. 1+ T cell development and early IL-4 production in CD1-deficient mice
6. CD1d1 mutant mice are deficient in natural T cells that promptly produce IL-4
7. Immunoglobulin E production in the absence of interleukin-4-secreting CD1-dependent cells
8. - (NKT) thymocytes prevent insulin-dependent diabetes mellitus in nonobese diabetic (NOD)/Lt mice by the influence of interleukin (IL)-4 and/or IL-10
9. CD1-reactive natural killer T cells are required for development of systemic tolerance through an immune-privileged site
10. The effect of α-galactosylceramide upon allogenic rejection
11. + T cells reciprocally regulate acute graft versus host disease
12. NKT cell-mediated repression of tumor immunosurveillance by IL-13 and the IL-4R-STAT6 pathway
13. + αβ T cells with intermediate TCR induced in the liver of mice by IL-12
14. The antitumor activity of IL-12: Mechanisms of innate immunity that are model and dose dependent
15. Natural killer-like nonspecific tumor cell lysis mediated by specific ligand-activated Vα14 NKT cells
16. Treatment of hepatic metastasis of the colon26 adenocarcinoma with an α-galactosylceramide, KRN7000
17. Cutting edge: Inhibition of experimental tumor metastasis by dendritic cells pulsed with α-galactosylceramide
18. Critical contribution of IFN-γ and NK cells, but not perforin-mediated cytotoxicity, to anti-metastatic effect of α-galactosylceramide
19. Mechanisms of the antimetastatic effect in the liver and of the hepatocyte injury induced by α-galactosylceramide in mice
20. Anti-metastatic effect of α-galactosylceramide is mediated by sequential production of IFN-γ by NKT and NK cells
21. Differential tumour surveillance by natural killer (NK) and NK T cells
22. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice
23. Multiple defects of immune cell function in mice with disrupted interferon-γ genes
24. NKT cells are phenotypically and functionally diverse
25. NK and NKT cells collaborate in host protection from MCA-induced fibrosarcoma
26. IFNγ and lymphocytes prevent primary turnout development and shape tumour immunogenicity
27. In vivo identification of glycolipid antigen-specific T cells using fluorescent CD1d tetramers
28. Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers
29. Cutting edge: Cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells
30. Selective induction of NK cell proliferation and cytotoxicity by activated NKT cells
31. Immune rejection of a large sarcoma following cyclophosphamide and IL-12 treatment requires both NK and NK T cells and is associated with the induction of a novel NK T cell population
32. + T cells are crucial for the ability of congenic normal mice to reject highly immunogenic sarcomas induced in nude mice with 3-methylcholanthrene
33. + cells upon NK T or T cell activation
34. Hypoxia-mediated apoptosis from angiogenesis inhibition underlies tumor control by recombinant interleukin 12
35. Evidence for the involvement of endothelial cell integrin αVβ3 in the disruption of the tumor vasculature induced by TNF and IFN-γ
36. Contribution of natural killer cells to inhibition of angiogenesis by interleukin-12
37. Fas/Fas ligand interactions promote activation-induced cell death of NK T lymphocytes
38. Activation of hepatic NKT cells and subsequent liver injury following administration α-galactosylceramide
39. An activating immunoreceptor complex formed by NKG2D and DAP10
40. NKT cells and tumor immunity - A double-edged sword
41. + T cells in IL-12-induced immune responses in vivo
42. IL-4-producing NK T cells are biased towards IFN-γ production by IL-12. Influence of the microenvironment on the functional capacities of NK T cells
43. + T cell-defective IL-4 production in the nonobese diabetic mouse
44. + T cells from IL 7-deficient mice have a normal distribution and selection but exhibit impaired cytokine production
45. - MHC class I-like/CD1-dependent CD4+ T cells